Inhibiting the apoptosis pathway using MDM2 in mammalian cell cultures
Nilou Arden1, Brian S Majors, Shin-Hyung Ahn
1Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA.
Biotechnology and Bioengineering
|December 7, 2006
Summary
Overexpressing MDM2 in mammalian cell cultures inhibits apoptosis, improving cell viability and density. This method enhances cell performance in batch and spent media conditions, offering a promising strategy for bioprocessing.
Area of Science:
- Biotechnology
- Cell Biology
- Molecular Biology
Background:
- Regulating apoptosis in mammalian cell cultures is key for efficient bioprocessing.
- Genetic modification with anti-apoptotic genes can enhance cellular performance.
Purpose of the Study:
- To investigate MDM2 overexpression as a method to inhibit upstream apoptosis pathways.
- To assess the impact of MDM2 on cell viability and density in 293 and CHO cells.
Main Methods:
- Overexpression of MDM2 in 293 and CHO cells.
- Culturing cells under batch and spent media conditions.
- Assessing cell viability, density, and DNA fragmentation via flow cytometry.
Main Results:
- MDM2 overexpression increased viable cell densities and viabilities in both cell types.
- MDM2-expressing CHO cells showed nearly double the viable cell density when passaged without medium exchange.
- MDM2-expressing cells exhibited slower DNA degradation compared to controls when exposed to spent media.
Conclusions:
- MDM2 overexpression effectively delays apoptosis in mammalian cell cultures.
- MDM2 provides greater protection against apoptosis than Bcl-2 under tested conditions.
- Heterologous MDM2 overexpression is a promising strategy for improving cell culture efficiency.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...